![](/img/cover-not-exists.png)
The eortc randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: Long-term results and side effects
Walter Van den Bogaert, Emmanuel van der Schueren, Jean-Claude Horiot, Mario De Vilhena, Simon Schraub, Vladimir Svoboda, Giorgio Arcangeli, Marleen de Pauw, Martine Van GlabbekeVolume:
20
Year:
1995
Language:
english
DOI:
10.1016/0958-3947(95)01538-r
File:
PDF, 126 KB
english, 1995